Eli Lilly launches migraine drug at $640 for 8 pills

Eli Lilly has priced its new migraine drug, Reyvow, at $640 for a pack of eight pills, according to PMLiVE

Reyvow was approved by the FDA last October and became available for prescription Jan. 31. 

Patients will not necessarily pay $640 for eight pills, depending on the duration of treatment and their healthcare plan. 

Eli Lilly also said it will offer a Reyvow savings card to eligible patients to help them lower their out-of-pocket costs. 

Read the full article here.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars